Skip Navigation

A Phase I Study of FT819 in Subjects with B-cell Malignancies

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04629729

Study #:
STUDY00146475

Start Date:
Aug 22, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04629729

View Complete Trial Details & Eligibility at ClinicalTrials.gov